Literature DB >> 6702971

Primary surgical repair of severe peripheral marginal ectasia in Terrien's marginal degeneration.

D R Caldwell, M S Insler, G Boutros, T Hawk.   

Abstract

We have developed a safe, successful, and simple procedure for repairing the severe peripheral marginal ectasia in Terrien's marginal degeneration. The area of ectasia is incised along its thinnest paralimbal dimension down to Descemet's membrane. Ectatic stroma along both sides of the incision is then undermined until normal-thickness stroma is reached. After excision of excess ectatic stroma, if necessary, the normal-thickness stroma is then sutured together, primarily with 9-0 Prolene. The sutures are left in place permanently, and the remaining refractive error is corrected with spectacles or contact lenses. This technique substantially improved visual acuity in three of four patients and decreased corneal astigmatism in all four. Although one eye required resuturing, there were no complications in any case.

Entities:  

Mesh:

Year:  1984        PMID: 6702971     DOI: 10.1016/0002-9394(84)90632-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Partial lamellar keratoplasty for peripheral corneal disease using a graft from the glycerin-preserved corneoscleral rim.

Authors:  Hua Gao; Xiuxian Wang; Jose J Echegaray; Suxia Li; Ting Wang; Weiyun Shi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-06       Impact factor: 3.117

2.  Peripheral deep anterior lamellar keratoplasty using a cryopreserved donor cornea for Terrien's marginal degeneration.

Authors:  Dan Huang; Wen-ya Qiu; Bei Zhang; Bing-hong Wang; Yu-feng Yao
Journal:  J Zhejiang Univ Sci B       Date:  2014-12       Impact factor: 3.066

3.  Ring-shaped corneoscleral lamellar keratoplasty guided by high-definition optical coherence tomography and Scheimpflug imaging for severe Terrien's marginal corneal degeneration.

Authors:  Ting Wang; Weiyun Shi; Gang Ding; Suxia Li; Mingna Liu; Hua Gao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-11       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.